Medtronic Acquires Influent Medical's Repose Product Line

Medtronic, Inc. (NYSE: MDT) announced today the acquisition of InfluENT Medical's Repose GAHM product line for the treatment of obstructive sleep apnea (OSA). The acquisition expands Medtronic's Surgical Technologies business unit portfolio of treatments for sleep-disordered breathing.

Financial terms of the agreement were not disclosed.

The Repose Genioglossus Advancement and Hyoid Advancement (GAHA) surgical devices advance the base of the tongue and the hyoid bone to prevent obstructions of the airway during sleep. In addition to the Repose System, the Surgical Technologies business of Medtronic offers the Pillar^® Palatal Implant System, used to treat the soft palate component of sleep breathing disorders, and an existing family of market-leading ENT instruments used to treat other upper airway obstructions.

"The Repose GAHM devices provide our surgeon customers with another minimally invasive, low morbidity option to treat patients suffering from OSA,” said Bob Blankemeyer, president of the Surgical Technologies business and senior vice president at Medtronic.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.

About InfluENT Medical

Headquartered in Concord, N.H., InfluENT Medical (www.influ-ent.com) is a privately held surgical device manufacturer of surgical products for the treatment of OSA.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's Annual Report on Form 10-K for the year ended April 25, 2008. Actual results may differ materially from anticipated results.

®Registered mark of Medtronic, Inc.